Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon on Diagnostic Imaging:
Breast Cancer Awareness month will soon be coming to a close, but that does not mean radiology practices and breast imaging centers should relax the attention they pay to patients who come in for breast cancer screening. This week, Diagnostic Imaging spoke with breast imaging technologist Stephanie Johnston from Solis Mammography in Texas about what is most important to women when they come in for annual screening, as well as what practices can do to ensure women have the best counters possible.
For additional insights on patient experience, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Stroke remains the leading cause of disability in the United States, as well as a leading cause of death. Given their skill set, radiologists are uniquely positioned for stroke prevention. In a column this week, Diagnostic Imaging Editorial Board member Mina Makary, M.D., an interventional radiologist from The Ohio State University Wexner Medical Center, shared insights on alternative training models for interventional neuroradiology.
To read our previous coverage of neuroimaging, click here.
Research efforts are continuing to help providers better understand the development of dementia in patients. This week, we will share investigation results from two institutions that shed light on how this disease affects the brain. Look for this coverage as the week progresses.
To read Diagnostic Imaging’s dementia coverage, click here.
GE HealthCare Launches AI Mammography Platform with Key Applications from iCAD
November 30th 2023Offering an all-in-one platform of artificial intelligence (AI) applications, MyBreastAI Suite reportedly facilitates early breast cancer detection and enhances efficiency with breast imaging workflows.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study: Black Patients Less Likely Than Others to Receive MRI Assessment of Cognitive Impairment
November 27th 2023In a four-year study of over 1,600 patients who had outpatient head CTs, head CT angiography and/or brain MRI to assess cognitive impairment, researchers found that Black patients were over 9 percent less likely than White patients and over 16 percent less likely than Hispanic patients to receive brain MRI.